Mycophenolate Oral Suspension
AssigneeLiqmeds Worldwide Limited
InventorsSandip MEHTA, Manish Kumar UMRETHIA, Jayanta MANDAL
Life of this patent
Estimating the term…
Abstract
Disclosed herein are pharmaceutical compositions in the form of a suspension for oral delivery. Some embodiments provide a pharmaceutical composition in the form of a suspension for oral delivery comprising an active pharmaceutical ingredient; water; a suspending agent; a buffering agent; and one or more of a wetting agent and a binder/filler. In some embodiments, the active pharmaceutical ingredient is selected from quetiapine, sildenafil, tadalafil, cinacalcet, ticagrelor, mycophenolate, aprepitant, zonisamide, and primidone.
Claims2
1-51. (canceled)
A pharmaceutical oral suspension, comprising:
- mycophenolate mofetil in an amount of about 200 mg/mL;
- a mycophenolate glycerol ester,
- one or more pharmaceutically acceptable excipients;
- and
- a vehicle comprising water.
Dependencies are inferred from the claim text.